AbCellera Biologics Inc. Accrued Income Taxes, Current
AbCellera Biologics Inc. (ABCL) had Accrued Income Taxes, Current of $15.04 million as of 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2023-08-03
- 2023-06-30: Accrued Income Taxes, Current $15.04M.
- 2022-12-31: Accrued Income Taxes, Current $48.00K.
- 2022-09-30: Accrued Income Taxes, Current $23.02M.
- 2022-06-30: Accrued Income Taxes, Current $107.32M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2023-06-30 | $15.04M 10-Q · filed 2023-08-03 |
| 2022-12-31 | $48.00K 10-Q · filed 2023-08-03 |
| 2022-09-30 | $23.02M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $107.32M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $105.65M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $35.68M 10-K · filed 2023-02-21 |
| 2021-09-30 | $6.59M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $5.82M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $30.03M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $36.15M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |